Clinical Trial Update: A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and feasibility of infusing donor-derived virus-specific T cells for post-transplant viral infections in hematopoietic stem …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenovirus Infection
• Cytomegalovirus Infection
• Epstein-barr Virus Infection

Drugs mentioned

• Cytokine Capture System (cytokine capture system)
• Virus-specific T cells (donor-derived) (virus-specific T cells)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Adenovirus Infection, EBV | Phase 2 | Status: RECRUITING